The inter-talk between Mycobacterium tuberculosis and the epigenetic mechanisms

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Baquero F. Epigenetics, epistasis and epidemics. Evol. Med. Public Health 2013(1), 86–88 (2013).
  MedlineGoogle Scholar
• 2. Waddington CH. The epigenotype. Int. J. Epidemiol. 41(1), 10–13 (2011).
  MedlineGoogle Scholar
• 3. De Monerri NCS, Kim K. Pathogens hijack the epigenome: a new twist on host-pathogen interactions. Am. J. Pathol. 184(4), 897–911 (2014).
  MedlineGoogle Scholar
• 4. Yadav V, Dwivedi V, Bhattacharya D, Mittal A, Moodley P. Understanding the Host Epigenetics in Mycobacterium tuberculosis. J. Infect. Dis. 2, 016 (2015). • This opinion study comprehensively provides a clear basis of epigenetic modifications that occur in the host upon tuberculosis (TB) infection and elaborates how Mycobacterium tuberculosis modulates the host epigenome.
  Google Scholar
• 5. Nicolia V, Lucarelli M, Fuso AJEG. Environment, epigenetics and neurodegeneration: focus on nutrition in Alzheimer’s disease. Exp. Gerontol. 68, 8–12 (2015).
  Medline CASGoogle Scholar
• 6. Levenson VV, Melnikov AA. DNA methylation as clinically useful biomarkers-light at the end of the tunnel. Pharmaceuticals 5(1), 94–113 (2012).
  Medline CASGoogle Scholar
• 7. Kathirvel M, Mahadevan S. The role of epigenetics in tuberculosis infection. Epigenomics 8(4), 537–549 (2016). • Authors discuss the principles and advances in induced epigenetic modifications upon TB infection and their effects on the host immune responses. They anticipated host susceptibility to Mycobacterium tuberculosis is critical for disease progression because of its epigenetic predisposition.
  CASGoogle Scholar
• 8. Yang T, Owen JL, Lightfoot YL, Kladde MP, Mohamadzadeh M. Microbiota impact on the epigenetic regulation of colorectal cancer. Trends Mol. Med. 19(12), 714–725 (2013).
  Medline CASGoogle Scholar
• 9. Danjuma L, Ling MP, Hamat RA et al. Genomic plasticity between human and mycobacterial DNA: a review. Tuberculosis 107, 38–47 (2017).
  Medline CASGoogle Scholar
• 10. Hullar MA, Fu BC. Diet, the gut microbiome, and epigenetics. Cancer J. 20(3), 170 (2014).
  Medline CASGoogle Scholar
• 11. World Health Organization. Global tuberculosis report 2018. (2018). www.who.int/tb/publications/global_report/en/
  Google Scholar
• 12. Chen Y, Lin M, Wu C, Leung S, Fang W, Chang H. Whole genome DNA methylation analysis of active pulmonary tuberculosis disease identifies novel epigenetic signatures. Am. J. Respir. Crit. Care Med. 197, 4321 (2018). •• An important original paper which hypothesized DNA methylation pattern may contribute to TB severity and development of its systemic symptoms.
  Google Scholar
• 13. Tarashi S, Badi SA, Moshiri A et al. The human microbiota in pulmonary tuberculosis: not so innocent bystanders. Tuberculosis 113, 215–221 (2018).
  Medline CASGoogle Scholar
• 14. Pennini ME, Pai RK, Schultz DC, Boom WH, Harding CV. Mycobacterium tuberculosis 19-kDa lipoprotein inhibits IFN-γ-induced chromatin remodeling of MHC2TA by TLR2 and MAPK signaling. J. Immunol. 176(7), 4323–4330 (2006).
  Medline CASGoogle Scholar
• 15. Kumar R, Halder P, Sahu SK et al. Identification of a novel role of ESAT‐6‐dependent miR‐155 induction during infection of macrophages with Mycobacterium tuberculosis. Cell. Microbiol. 14(10), 1620–1631 (2012).
  Medline CASGoogle Scholar
• 16. Wang Y, Curry HM, Zwilling BS, Lafuse WP. Mycobacteria inhibition of IFN-γ induced HLA-DR gene expression by up-regulating histone deacetylation at the promoter region in human THP-1 monocytic cells. J. Immunol. 174(9), 5687–5694 (2005).
  Medline CASGoogle Scholar
• 17. Yaseen I, Kaur P, Nandicoori VK, Khosla S. Mycobacteria modulate host epigenetic machinery by Rv1988 methylation of a non-tail arginine of histone H3. Nat. Commun. 6, 8922 (2015).
  Medline CASGoogle Scholar
• 18. Jose L, Ramachandran R, Bhagavat R et al. Hypothetical protein Rv3423.1 of Mycobacterium tuberculosis is a histone acetyltransferase. FEBS J. 283(2), 265–281 (2016).
  Medline CASGoogle Scholar
• 19. Sharma G, Upadhyay S, Srilalitha M, Nandicoori VK, Khosla S. The interaction of mycobacterial protein Rv2966c with host chromatin is mediated through non-CpG methylation and histone H3/H4 binding. Nucleic Acids Res. 43(8), 3922–3937 (2015). • This original research explores the role of Rv2966c in DNA methylation modulating in the host cells. Authors addressed that while CpG methylation is introduced as the normal mode of DNA methylation, Rv2966c may induce methylation in non-CpG sites upon TB infection.
  Medline CASGoogle Scholar
• 20. Chandran A, Antony C, Jose L, Mundayoor S, Natarajan K, Kumar RA. Mycobacterium tuberculosis infection induces HDAC1-mediated suppression of IL-12B gene expression in macrophages. Front. Cell. Infect. Microbiol. 5, 90 (2015).
  MedlineGoogle Scholar
• 21. Duan L, Yi M, Chen J, Li S, Chen W. Mycobacterium tuberculosis EIS gene inhibits macrophage autophagy through up-regulation of IL-10 by increasing the acetylation of histone H3. Biochem. Biophys. Res. Commun. 473(4), 1229–1234 (2016).
  Medline CASGoogle Scholar
• 22. Bouttier M, Laperriere D, Memari B et al. Alu repeats as transcriptional regulatory platforms in macrophage responses to M. tuberculosis infection. Nucleic Acids Res. 44(22), 10571–10587 (2016).
  Medline CASGoogle Scholar
• 23. Sengupta S, Naz S, Das I et al. Mycobacterium tuberculosis EsxL inhibits MHC-II expression by promoting hypermethylation in class-II transactivator loci in macrophages. J. Biol. Chem. 292(17), 6855–6868 (2017).
  Medline CASGoogle Scholar
• 24. Moores RC, Brilha S, Schutgens F, Elkington PT, Friedland JS. Epigenetic regulation of matrix metalloproteinase-1 and-3 expression in Mycobacterium tuberculosis infection. Front. Immunol. 8, 602 (2017).
  MedlineGoogle Scholar
• 25. Singh V, Prakhar P, Rajmani RS, Mahadik K, Borbora SM, Balaji KN. Histone methyltransferase SET8 epigenetically reprograms host immune responses to assist mycobacterial survival. J. Infect. Dis. 216(4), 477–488 (2017).
  Medline CASGoogle Scholar
• 26. Wang X, Wu Y, Jiao J, Huang Q. Mycobacterium tuberculosis infection induces IL-10 gene expression by disturbing histone deacetylase 6 and histonedeacetylase 11 equilibrium in macrophages. Tuberculosis (Edinb) 108, 118–123 (2018).
  Medline CASGoogle Scholar
• 27. Ghosh S, Padmanabhan B, Anand C, Nagaraja V. Lysine acetylation of the Mycobacterium tuberculosis HU protein modulates its DNA binding and genome organization. Mol. Microbiol. 100(4), 577–588 (2016).
  Medline CASGoogle Scholar
• 28. Anand C, Garg R, Ghosh S, Nagaraja V. A Sir2 family protein Rv1151c deacetylates HU to alter its DNA binding mode in Mycobacterium tuberculosis. Biochem. Biophys. Res. Commun. 493(3), 1204–1209 (2017).
  Medline CASGoogle Scholar
• 29. Yaseen I, Choudhury M, Sritharan M, Khosla S. Histone methyltransferase SUV39H1 participates in host defense by methylating mycobacterial histone-like protein HupB. EMBO J. 37(2), 183–200 (2018).
  Medline CASGoogle Scholar
• 30. Green KD, Biswas T, Pang AH et al. Acetylation by Eis and deacetylation by Rv1151c of Mycobacterium tuberculosis HupB: biochemical and structural insight. Biochemistry 57(5), 781–790 (2018).
  Medline CASGoogle Scholar
• 31. Pacis A, Tailleux L, Morin AM et al. Bacterial infection remodels the DNA methylation landscape of human dendritic cells. Genome Res. 25(12), 1801–1811 (2015).
  Medline CASGoogle Scholar
• 32. Zheng L, Leung ET, Wong H et al. Unraveling methylation changes of host macrophages in Mycobacterium tuberculosis infection. Tuberculosis 98, 139–148 (2016).
  Medline CASGoogle Scholar
• 33. Sharma G, Sowpati DT, Singh P et al. Genome-wide non-CpG methylation of the host genome during M. tuberculosis infection. Sci. Rep. 6, 25006 (2016). • An important original research that indicates association of genome-wide non-CpG DNA methylation and modulating host gene expression upon TB infection.
  Medline CASGoogle Scholar
• 34. Wei M, Wang L, Wu T et al. NLRP3 activation was regulated by DNA methylation modification during Mycobacterium tuberculosis infection. Biomed. Res. Int. 2016, 1–10 (2016).
  CASGoogle Scholar
• 35. Koh H-J, Kim Y-R, Kim J-S et al. CD82 hypomethylation is essential for tuberculosis pathogenesis via regulation of RUNX1-Rab5/22. Exp. Mol. Med. 50(5), 62 (2018).
  Google Scholar
• 36. Pacis A, Mailhot-Leonard F, Tailleux L et al. Gene activation precedes DNA demethylation in response to infection in human dendritic cells. Proc. Natl Acad. Sci. USA 116(14), 6938–6943 (2019). • This paper highlights the importance of whole genome DNA methylation landscape of human dendritic cells upon TB infection.
  Medline CASGoogle Scholar
• 37. Andraos C, Koorsen G, Knight JC, Bornman L. Vitamin D receptor gene methylation is associated with ethnicity, tuberculosis, and TaqI polymorphism. Hum. Immunol. 72(3), 262–268 (2011).
  Medline CASGoogle Scholar
• 38. Chen Y-C, Hsiao C-C, Chen C-J et al. Aberrant Toll-like receptor 2 promoter methylation in blood cells from patients with pulmonary tuberculosis. J. Infect. 69(6), 546–557 (2014).
  MedlineGoogle Scholar
• 39. He L, Gao L, Shi Z et al. Involvement of cytochrome P450 1A1 and glutathione S-transferase P1 polymorphisms and promoter hypermethylation in the progression of anti-tuberculosis drug-induced liver injury: a case–control study. PloS ONE 10(3), e0119481 (2015).
  MedlineGoogle Scholar
• 40. Esterhuyse MM, Weiner J, Caron E et al. Epigenetics and proteomics join transcriptomics in the quest for tuberculosis biomarkers. MBio 6(5), e01187–e01115 (2015).
  Medline CASGoogle Scholar
• 41. Zhang J, Zhu X, Li Y et al. Correlation of CpG Island methylation of the cytochrome P450 2E1/2D6 genes with liver injury induced by anti-tuberculosis drugs: a nested case–control study. Int. J. Environ. Res. Public Health 13(8), 776 (2016).
  Google Scholar
• 42. Jiang C, Zhu J, Liu Y et al. The methylation state of VDR gene in pulmonary tuberculosis patients. J. Thorac. Dis. 9(11), 4353 (2017).
  MedlineGoogle Scholar
• 43. Wang M, Kong W, He B et al. Vitamin D and the promoter methylation of its metabolic pathway genes in association with the risk and prognosis of tuberculosis. Clin. Epigenetics 10(1), 118 (2018).
  MedlineGoogle Scholar
• 44. Dinardo AR, Nishiguchi T, Mace EM et al. Schistosomiasis induces persistent DNA methylation and tuberculosis-specific immune changes. J. Immunol. 201(1), 124–133 (2018).
  Medline CASGoogle Scholar
• 45. Maruthai K, Subramanian M. Methylation status of alu repetitive elements in children with tuberculosis disease. Int. J. Mycobacteriol. 7(3), 242 (2018).
  Medline CASGoogle Scholar
• 46. Maruthai K, Kalaiarasan E, Joseph NM, Parija SC, Mahadevan S. Assessment of global DNA methylation in children with tuberculosis disease. Int. J. Mycobacteriol. 7(4), 338 (2018).
  Medline CASGoogle Scholar
• 47. Hamon MA, Cossart P. Histone modifications and chromatin remodeling during bacterial infections. Cell Host Microbe 4(2), 100–109 (2008).
  Medline CASGoogle Scholar
• 48. Tremethick DJ. Higher-order structures of chromatin: the elusive 30 nm fiber. Cell 128(4), 651–654 (2007).
  Medline CASGoogle Scholar
• 49. Mohrmann L, Verrijzer CP. Composition and functional specificity of SWI2/SNF2 class chromatin remodeling complexes. Biochim. Biophys. Acta 1681(2–3), 59–73 (2005).
  Medline CASGoogle Scholar
• 50. Kouzarides T. Chromatin modifications and their function. Cell 128(4), 693–705 (2007).
  Medline CASGoogle Scholar
• 51. Rae W. Indications to epigenetic dysfunction in the pathogenesis of common variable immunodeficiency. Arch. Immunol. Ther. Exp. 65(2), 101–110 (2017).
  Medline CASGoogle Scholar
• 52. Kumar P, Agarwal R, Siddiqui I, Vora H, Das G, Sharma P. ESAT6 differentially inhibits IFN‐γ‐inducible class II transactivator isoforms in both a TLR2‐dependent and‐independent manner. Immunol. Cell Biol. 90(4), 411–420 (2012).
  Medline CASGoogle Scholar
• 53. Dunne PJ, Richard G, Keane J. Commercially available, FDA-approved epigenetic modifiers as therapeutic agents in bacterial infection. Antiinflamm. Antiallergy. Drug 2(1), 79–88 (2015).
  CASGoogle Scholar
• 54. Chen Y-C, Chao T-Y, Leung S-Y et al. Histone H3K14 hypoacetylation and H3K27 hypermethylation along with HDAC1 up-regulation and KDM6B down-regulation are associated with active pulmonary tuberculosis disease. Am. J. Transl. Res. 9(4), 1943 (2017).
  Medline CASGoogle Scholar
• 55. Shilatifard A. Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu. Rev. Biochem. 75, 243–269 (2006).
  Medline CASGoogle Scholar
• 56. Gringhuis SI, Den Dunnen J, Litjens M, Van Het Hof B, Van Kooyk Y, Geijtenbeek TB. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB. Immunity 26(5), 605–616 (2007).
  Medline CASGoogle Scholar
• 57. Sánchez A, Espinosa P, García T, Mancilla R. The 19kDa Mycobacterium tuberculosis lipoprotein (LpqH) induces macrophage apoptosis through extrinsic and intrinsic pathways: a role for the mitochondrial apoptosis-inducing factor. Clin. Dev. Immunol. 2012, 950503 (2012).
  MedlineGoogle Scholar
• 58. Kim KH, An DR, Song J et al. Mycobacterium tuberculosis Eis protein initiates suppression of host immune responses by acetylation of DUSP16/MKP-7. Proc. Natl Acad. Sci. USA 109(20), 7729–7734 (2012).
  Medline CASGoogle Scholar
• 59. Crossman DK. Characterization of a novel acetyltransferase found only in pathogenic strains of Mycobacterium tuberculosis. University of Alabama, Birmingham, Alabama, USA (2007). Google Scholar
  Google Scholar
• 60. Moores R, Rand L, Elkington P, Friedland J. Matrix metalloproteinase-1 expression in tuberculosis is regulated by histone acetylation: p2151. Clin. Microbiol. Infect. 18, 626–627 (2012).
  MedlineGoogle Scholar
• 61. Deaton AM, Bird A. CpG islands and the regulation of transcription. Genes Dev. 25(10), 1010–1022 (2011).
  Medline CASGoogle Scholar
• 62. Zhang G, Pradhan S. Mammalian epigenetic mechanisms. IUBMB Life 66(4), 240–256 (2014). •• An important review in this field discussing the different layers of epigenetic modifications and their role in various cellular processes in eukaryotic cells.
  Medline CASGoogle Scholar
• 63. Fuso AJCC, Medicine L. The ‘golden age’of DNA methylation in neurodegenerative diseases. Clin. Chem. Lab. Med. 51(3), 523–534 (2013).
  Medline CASGoogle Scholar
• 64. Siedlecki P, Zielenkiewicz P. Mammalian DNA methyltransferases. Acta Biochim. Pol. 53(2), 245 (2006).
  Medline CASGoogle Scholar
• 65. Klose RJ, Bird AP. Genomic DNA methylation: the mark and its mediators. Trends Biochem. Sci. 31(2), 89–97 (2006).
  Medline CASGoogle Scholar
• 66. Illingworth RS, Bird AP. CpG islands–‘a rough guide’. FEBS Lett. 583(11), 1713–1720 (2009).
  Medline CASGoogle Scholar
• 67. Ponnaluri VC, Estève P-O, Ruse CI, Pradhan S. S-adenosylhomocysteine hydrolase participates in DNA methylation inheritance. J. Mol. Biol. 430(14), 2051–2065 (2018).
  Medline CASGoogle Scholar
• 68. Sandoval J et al. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics 6(6), 692–702 (2011).
  Medline CASGoogle Scholar
• 69. Fuso A, Ferraguti G, Grandoni F et al. Early demethylation of non-CpG, CpC-rich, elements in the myogenin 5’-flanking region: a priming effect on the spreading of active demethylation? Cell Cycle 9(19), 3965–3976 (2010).
  Medline CASGoogle Scholar
• 70. Fuso A, Scarpa S, Grandoni F, Strom R, Lucarelli M. A reassessment of semiquantitative analytical procedures for DNA methylation: comparison of bisulfite-and HpaII polymerase-chain-reaction-based methods. Anal. Biochem. 350(1), 24–31 (2006).
  Medline CASGoogle Scholar
• 71. Warrier T, Kapilashrami K, Argyrou A et al. N-methylation of a bactericidal compound as a resistance mechanism in Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 113(31), E4523–E4530 (2016).
  Medline CASGoogle Scholar
• 72. Kinney SRM, Pradhan S. Regulation of expression and activity of DNA (cytosine-5) methyltransferases in mammalian cells. Prog. Mol. Biol. Transl. Sci. 101, 311–333 (2011).
  Medline CASGoogle Scholar
• 73. Okano M, Bell DW, Haber DA, Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99(3), 247–257 (1999).
  Medline CASGoogle Scholar
• 74. Okano M, Xie S, Li EJNG. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat. Genet. 19(3), 219 (1998).
  Medline CASGoogle Scholar
• 75. Fuso A, Ferraguti G, Scarpa S, Ferrer I, Lucarelli M. Disclosing bias in bisulfite assay: methPrimers underestimate high DNA methylation. PLoS ONE 10(2), e0118318 (2015). • A research study that addresses the aberrant DNA methylation more largely induced at the low CpG density regions rather than high CpG density upon TB infection.
  MedlineGoogle Scholar
• 76. Hata K, Okano M, Lei H, Li E. Dnmt3L cooperates with the Dnmt3 family of de novo DNA methyltransferases to establish maternal imprints in mice. Development 129(8), 1983–1993 (2002).
  Medline CASGoogle Scholar
• 77. Jeltsch A, Ehrenhofer-Murray A, Jurkowski TP et al. Mechanism and biological role of Dnmt2 in nucleic acid methylation. Trends Biochem. Sci. 14(9), 1108–1123 (2017).
  Google Scholar
• 78. Dev RR, Ganji R, Singh SP, Mahalingam S, Banerjee S, Khosla S. Cytosine methylation by DNMT2 facilitates stability and survival of HIV-1 RNA in the host cell during infection. Biochem. J. 474(12), 2009–2026 (2017).
  Medline CASGoogle Scholar
• 79. Shell SS, Prestwich EG, Baek S-H et al. DNA methylation impacts gene expression and ensures hypoxic survival of Mycobacterium tuberculosis. PLoS. Pathog. 9(7), e1003419 (2013).
  Medline CASGoogle Scholar
• 80. Marimani M, Ahmad A, Duse A. The role of epigenetics, bacterial and host factors in progression of Mycobacterium tuberculosis infection. Tuberculosis 113, 200–214 (2018). •• A review study with a brief discussion about various mechanisms, as well as epigenetics, employed during TB infection to suppress host immune system.
  Medline CASGoogle Scholar
• 81. Auwerx J. The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte–macrophage differentiation. Experientia 47(1), 22–31 (1991).
  Medline CASGoogle Scholar
• 82. Pieters J. Mycobacterium tuberculosis and the macrophage: maintaining a balance. Cell Host Microbe 3(6), 399–407 (2008).
  Medline CASGoogle Scholar
• 83. Mihret A. The role of dendritic cells in Mycobacterium tuberculosis infection. Virulence 3(7), 654–659 (2012).
  MedlineGoogle Scholar
• 84. Li C-W, Lee Y-L, Chen B-S. Genetic-and-epigenetic interspecies networks for cross-talk mechanisms in human macrophages and dendritic cells during MTB infection. Front. Cell. Infect. Microbiol. 6, 124 (2016).
  MedlineGoogle Scholar
• 85. Van Der Heijden CD, Noz MP, Joosten LA, Netea MG, Riksen NP, Keating ST. Epigenetics and trained immunity. Antioxid. Redox Signal. 29(11), 1023–1040 (2018).
  MedlineGoogle Scholar
• 86. Pereira JM, Hamon MA, Cossart P. A lasting impression: epigenetic memory of bacterial infections? Cell Host Microbe 19(5), 579–582 (2016).
  Medline CASGoogle Scholar
• 87. Sánchez-Romero MA, Cota I, Casadesús J. DNA methylation in bacteria: from the methyl group to the methylome. Curr. Opin. Microbiol. 25, 9–16 (2015).
  Medline CASGoogle Scholar
• 88. Malone KM, Gordon SV. Antibiotic methylation: a new mechanism of antimicrobial resistance. Trends Microbiol. 24(10), 771–772 (2016). •• A new study on a novel mode of tuberculosis drug resistance by epigenetic mechanisms.
  Medline CASGoogle Scholar
• 89. Liu Y, Li H, Xiao T, Lu Q. Epigenetics in immune-mediated pulmonary diseases. Clin. Rev. Allergy Immunol. 45(3), 314–330 (2013).
  Medline CASGoogle Scholar
• 90. Borchert GM, Lanier W, Davidson BL. RNA polymerase III transcribes human microRNAs. Nat. Struct. Mol. Biol. 13(12), 1097 (2006).
  Medline CASGoogle Scholar
• 91. Cai X, Hagedorn CH, Cullen BR. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 10(12), 1957–1966 (2004).
  Medline CASGoogle Scholar
• 92. Bentwich I, Avniel A, Karov Y et al. Identification of hundreds of conserved and nonconserved human microRNAs. Nat. Genet. 37(7), 766 (2005).
  Medline CASGoogle Scholar
• 93. Wang C, Yang S, Sun G et al. Comparative miRNA expression profiles in individuals with latent and active tuberculosis. PloS ONE 6(10), e25832 (2011).
  Medline CASGoogle Scholar
• 94. Wu Z, Lu H, Sheng J, Li L. Inductive microRNA‐21 impairs anti‐mycobacterial responses by targeting IL‐12 and Bcl‐2. FEBS Lett. 586(16), 2459–2467 (2012).
  Medline CASGoogle Scholar
• 95. Ni B, Rajaram MV, Lafuse WP, Landes MB, Schlesinger LS. Mycobacterium tuberculosis decreases human macrophage IFN-γ responsiveness through miR-132 and miR-26a. J. Immunol. 193(9), 4537–4547 (2014).
  Medline CASGoogle Scholar
• 96. Ma F, Xu S, Liu X et al. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ. Nat. Immunol. 12(9), 861 (2011).
  Medline CASGoogle Scholar
• 97. Singh Y, Kaul V, Mehra A et al. Mycobacterium tuberculosis controls microRNA-99b (miR-99b) expression in infected murine dendritic cells to modulate host immunity. J. Biol. Chem. 288(7), 5056–5061 (2013).
  Medline CASGoogle Scholar
• 98. Rajaram MV, Ni B, Morris JD et al. Mycobacterium tuberculosis lipomannan blocks TNF biosynthesis by regulating macrophage MAPK-activated protein kinase 2 (MK2) and microRNA miR-125b. Proc. Natl Acad. Sci. USA 108(42), 17408–17413 (2011).
  Medline CASGoogle Scholar
• 99. Liu Y, Wang X, Jiang J, Cao Z, Yang B, Cheng X. Modulation of T cell cytokine production by miR-144* with elevated expression in patients with pulmonary tuberculosis. Mol. Immunol. 48(9–10), 1084–1090 (2011).
  Medline CASGoogle Scholar
• 100. Li S, Yue Y, Xu W, Xiong S. MicroRNA-146a represses mycobacteria-induced inflammatory response and facilitates bacterial replication via targeting IRAK-1 and TRAF-6. PloS ONE 8(12), e81438148 (2013).
  Google Scholar
• 101. Yi Z, Fu Y, Ji R, Li R, Guan Z. Altered microRNA signatures in sputum of patients with active pulmonary tuberculosis. PloS ONE 7(8), e43184 (2012). •• For the first time, the profile of miRNA expression in sputum was evaluated during TB infection. The important role of miRNAs in the pathonegenesis, diagnosis and prognosis of TB infection is confirmed.
  Medline CASGoogle Scholar
• 102. Thai T-H, Calado DP, Casola S et al. Regulation of the germinal center response by microRNA-155. Science 316(5824), 604–608 (2007).
  Medline CASGoogle Scholar
• 103. Wu J, Lu C, Diao N et al. Analysis of microRNA expression profiling identifies miR-155 and miR-155* as potential diagnostic markers for active tuberculosis: a preliminary study. Hum. Immunol. 73(1), 31–37 (2012).
  Medline CASGoogle Scholar
• 104. Wei J, Huang X, Zhang Z et al. MyD88 as a target of microRNA-203 in regulation of lipopolysaccharide or Bacille Calmette-Guerin induced inflammatory response of macrophage RAW264. 7 cells. Cell. Mol. Immunol. 55(3–4), 303–309 (2013).
  CASGoogle Scholar
• 105. Dorhoi A, Iannaccone M, Farinacci M et al. MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment. J. Clin. Investig. 123(11), 4836–4848 (2013).
  Medline CASGoogle Scholar
• 106. Spinelli SV, Diaz A, D’attilio L et al. Altered microRNA expression levels in mononuclear cells of patients with pulmonary and pleural tuberculosis and their relation with components of the immune response. Cell. Mol. Immunol. 53(3), 265–269 (2013).
  CASGoogle Scholar
• 107. Kumar M, Sahu SK, Kumar R et al. MicroRNA let-7 modulates the immune response to Mycobacterium tuberculosis infection via control of A20, an inhibitor of the NF-κB pathway. Cell Host Microbe 17(3), 345–356 (2015).
  MedlineGoogle Scholar
• 108. Ueberberg B, Kohns M, Mayatepek E, Jacobsen M. Are microRNAs suitable biomarkers of immunity to tuberculosis? Mol. Cell. Probes 1(1), 8 (2014).
  Google Scholar